Testing effectiveness (Phase 2)Study completedNCT02161952What this trial is testingPirfenidone, an Antifibrotic and Antiinflammatory DrugWho this might be right forFibrosisHepatitis C Chronic University of Guadalajara 150
Testing effectiveness (Phase 2)Study completedNCT01888900What this trial is testingNew Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis CWho this might be right forCirrhosisChronic Hepatitis CHepatitis C+1 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35
Not applicableEnded earlyNCT00867243What this trial is testingPrediction of Hepatitis C Recurrence in Liver Transplant RecipientsWho this might be right forComplication of Transplanted LiverHepatitis C, Chronic Northwestern University 24
Large-scale testing (Phase 3)Study completedNCT02597166What this trial is testingEffects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 InfectionWho this might be right forHepatitis C, ChronicCirrhosis, Decompensated University Health Network, Toronto 14
Early research (Phase 1)UnknownNCT00832247What this trial is testingAutologous Bone Marrow Mononuclear Cells in Liver CirrhosisWho this might be right forLiver Cirrhosis Due to Virus C Chronic Hepatitis Universidade Federal do Rio de Janeiro 15
Not applicableUnknownNCT04191018What this trial is testingGastrOesophageal Varices After Sustained Virological ResponseWho this might be right forLiver DiseasesHepatitis C Oswaldo Cruz Foundation 322
Not applicableEnded earlyNCT01951209What this trial is testingPilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisWho this might be right forLiver CirrhosisChronic Hepatitis C David E. Kaplan, MD MSc 13